Your browser doesn't support javascript.
loading
Dyserythropoiesis evaluated by the RED score and hepcidin:ferritin ratio predicts response to erythropoietin in lower-risk myelodysplastic syndromes.
Park, Sophie; Kosmider, Olivier; Maloisel, Frédéric; Drenou, Bernard; Chapuis, Nicolas; Lefebvre, Thibaud; Karim, Zoubida; Puy, Hervé; Alary, Anne Sophie; Ducamp, Sarah; Verdier, Frédérique; Bouilloux, Cécile; Rousseau, Alice; Jacob, Marie-Christine; Debliquis, Agathe; Charpentier, Agnes; Gyan, Emmanuel; Anglaret, Bruno; Leyronnas, Cecile; Corm, Selim; Slama, Borhane; Cheze, Stephane; Laribi, Kamel; Amé, Shanti; Rose, Christian; Lachenal, Florence; Toma, Andrea; Pica, Gian Matteo; Carre, Martin; Garban, Frédéric; Mariette, Clara; Cahn, Jean-Yves; Meunier, Mathieu; Herault, Olivier; Fenaux, Pierre; Wagner-Ballon, Orianne; Bardet, Valerie; Dreyfus, Francois; Fontenay, Michaela.
Afiliación
  • Park S; Department of Hematology, CHU Grenoble-Alpes, Grenoble spark@chu-grenoble.fr.
  • Kosmider O; Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, Grenoble.
  • Maloisel F; Assistance Publique-Hôpitaux de Paris (AP-HP), Service d'Hématologie Biologique, Hôpitaux Universitaires Paris Centre, Institut Cochin, Université Paris Descartes.
  • Drenou B; SOL Hematology, Clinique Saint Anne, Strasbourg.
  • Chapuis N; Department of Hematology, Hôpital Emile Muller, CH de Mulhouse.
  • Lefebvre T; INSERM UMR1149, CNRS 8252 - Centre de Recherche sur l'Inflammation (CRI) Equipe "Hème, Fer et Pathologies Inflammatoires", Labex GREX, Centre Français des Porphyries - Hôpital Louis Mourier HUPNVS, Paris.
  • Karim Z; Institut Cochin, INSERM U1016, CNRS UMR 8104, Paris Descartes University.
  • Puy H; INSERM UMR1149, CNRS 8252 - Centre de Recherche sur l'Inflammation (CRI) Equipe "Hème, Fer et Pathologies Inflammatoires", Labex GREX, Centre Français des Porphyries - Hôpital Louis Mourier HUPNVS, Paris.
  • Alary AS; INSERM UMR1149, CNRS 8252 - Centre de Recherche sur l'Inflammation (CRI) Equipe "Hème, Fer et Pathologies Inflammatoires", Labex GREX, Centre Français des Porphyries - Hôpital Louis Mourier HUPNVS, Paris.
  • Ducamp S; Assistance Publique-Hôpitaux de Paris (AP-HP), Service d'Hématologie Biologique, Hôpitaux Universitaires Paris Centre, Institut Cochin, Université Paris Descartes.
  • Verdier F; Institut Cochin, INSERM U1016, CNRS UMR 8104, Paris Descartes University.
  • Bouilloux C; Institut Cochin, INSERM U1016, CNRS UMR 8104, Paris Descartes University.
  • Rousseau A; Department of Hematology, CHU Grenoble-Alpes, Grenoble.
  • Jacob MC; Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, Grenoble.
  • Debliquis A; Institut Cochin, INSERM U1016, CNRS UMR 8104, Paris Descartes University.
  • Charpentier A; Institut de Biologie et Pathologie, Immunology, CHU Grenoble-Alpes, Grenoble.
  • Gyan E; Hematology Laboratory, Mulhouse Hospital.
  • Anglaret B; Department of Hematology, Hôpital St Philibert, Lille.
  • Leyronnas C; Department of Hematology, CHU de Tours.
  • Corm S; CH de Valence.
  • Slama B; Institut Daniel Hollard, Grenoble.
  • Cheze S; Medipole de Savoie, Challes les Eaux.
  • Laribi K; Department of Hematology, CH d'Avignon.
  • Amé S; Department of Hematology, CHU Caen.
  • Rose C; Department of Hematology , CH Le Mans.
  • Lachenal F; Department of Hematology, Hôpital Civil, CHU Strasbourg.
  • Toma A; Department of Hematology, Hôpital Saint Vincent de Paul, Lille.
  • Pica GM; Department of Hematology CH Pierre Oudot, Bourgoin-Jallieu.
  • Carre M; Department of Hematology, Hôpital Universitaire Henri Mondor, AP-HP, Université Paris 12, Créteil.
  • Garban F; Department of Hematology, CH Métropole Savoie, Chambery.
  • Mariette C; Department of Hematology, CHU Grenoble-Alpes, Grenoble.
  • Cahn JY; Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, Grenoble.
  • Meunier M; Department of Hematology, CHU Grenoble-Alpes, Grenoble.
  • Herault O; Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, Grenoble.
  • Fenaux P; Department of Hematology, CHU Grenoble-Alpes, Grenoble.
  • Wagner-Ballon O; Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, Grenoble.
  • Bardet V; Department of Hematology, CHU Grenoble-Alpes, Grenoble.
  • Dreyfus F; Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, Grenoble.
  • Fontenay M; Department of Hematology, CHU Grenoble-Alpes, Grenoble.
Haematologica ; 104(3): 497-504, 2019 03.
Article en En | MEDLINE | ID: mdl-30287621
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Eritropoyetina / Eritropoyesis / Ferritinas / Hepcidinas Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Año: 2019 Tipo del documento: Article Pais de publicación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Eritropoyetina / Eritropoyesis / Ferritinas / Hepcidinas Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Año: 2019 Tipo del documento: Article Pais de publicación: Italia